Format

Send to

Choose Destination
Chin Med. 2018 Dec 17;13:62. doi: 10.1186/s13020-018-0219-4. eCollection 2018.

Cardiac function evaluation for a novel one-step detoxification product of Aconiti Lateralis Radix Praeparata.

Author information

1
1State Key Laboratory Breeding Base of Systematic Research, Development and Utilization of Chinese Medicine Resources, Development and Utilization of Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu, People's Republic of China.
2
Sichuan Good Doctor Panxi Pharmaceutical Co., LTD, Xichang, China.
3
3Central Laboratory, Teaching Hospital of Chengdu University of TCM, Chengdu, People's Republic of China.
4
4China Military Institute of Chinese Medicine, 302 Military Hospital, No. 100 Xisihuan, Beijing, 100039 People's Republic of China.
5
5Department of Pharmacy and Chemistry, Dali University, Dali, People's Republic of China.
6
6Jiangxi University of Traditional Chinese Medicine, No. 18 Yunwan Avenue, Nanchang, 330004 People's Republic of China.
#
Contributed equally

Abstract

Background:

Aconiti Lateralis Radix Praeparata has been used as the first cardiac drug over a 1000 years in Asian countries. Although most detoxification products are confirmed to be safe, the effect is not potent as desired. In previous study, we designed a one-step detoxification product by fresh cutting and continuously dried, which preserved more water-soluble alkaloids while eliminating toxicity. It is thus necessary to find more in vivo evidence to support its industrial development.

Methods:

Initially, network pharmacology was applied to analyze the related pathways of candidate components acting on heart failure diseases. Then, two heart failure models that were induced by propafenone hydrochloride and nimodipine (v/v, 1:1) and were given doxorubicin were carried out to test the cardiac activity. Moreover, the effect on mitochondrial energy metabolism was further assessed.

Results:

Network pharmacology results indicated that Aconiti Lateralis Radix Praeparata treated heart failure through cAMP signaling pathway, calcium signaling pathway, adrenergic signaling in cardiomyocytes and so on. These pathways were highly correlated with myocardial contractility and mitochondrial energy metabolism. Trials on heart failure rats demonstrated that the novel processed-product could produce a stronger positive inotropic action and increase more Na +-K +-ATPase and Ca 2+-Mg 2+-ATPase than Heishunpian. Pathological results also revealed the novel one could better restore the morphology of cardiomyocytes and reduce vacuolar lesions. It also could inspire more energy with a lower concentration.

Conclusions:

This study provides scientific evidence for the clinical application of new products. It is of great benefit to innovate the industrial detoxification process of Aconitum.

KEYWORDS:

Aconiti Lateralis Radix Praeparata; Cardiac function; Detoxification approach; Mitochondrial energy metabolism; Network pharmacology

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center